Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J Clin Virol. 2012 May 24;54(4):313–317. doi: 10.1016/j.jcv.2012.04.022

Table 2.

Comparison of RVFV in whole blood and plasma samples.

Patient Days
(p.o.)
Whole Blood
(Ct)
Plasma
(Ct)
A 20 29.5 37.8
B 16 35.0 >45.0
C 15 35.1 n.d.
D 4 16.8 16.5
E 7 23.4 23.8
F 11 32.1 36.1
G 6 30.0 40.0
H 10 36.5 n.d.

Apparent viral genome loads in whole blood and plasma are equivalent for high titer patients (Ct values <25) but become increasingly disparate as viral genome titers decrease (Ct values >25). Key: Ct = cycle threshold; n.d. = not detectable (no amplification present - negative); >45 = amplification was present but did not reach threshold within 45 cycles, considered negative; p.o. = post onset of clinical symptoms